Summarized by Masters of Longevity from Nature - Biotechnology.
A PLVAP promoter reporter in human iPS cells marked endothelial-like differentiation and angiogenic activity in ischemic models.
Key Takeaways
- Researchers inserted a PLVAP promoter reporter into human iPS cells.
- Derived endothelial-like cells showed eNOS-dependent nitric oxide responses.
- Transplanted iEC improved perfusion recovery but causality is observational.
